Skip to main content

Table 5 Predicted utilities from 3 scenarios

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

  Possible QLQ-C30 Score Predicted
Model Function Symptom EQ-5D-3L EQ-5D-5L
Random effects Best (100) Best (0) 0.89 0.96
  Worst (0) Worst (100) 0.10 0.019
Beta Binomial Best (100) Best (0) 0.901 0.983
  Worst (0) Worst (100) 0.097 0.0094
LDVMM Best (100) Best (0) 0.884 0.972
  Worst (0) Worst (100) 0.055 0.008